These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 7860398)
21. Radiobiological predictors of tumor and acute normal tissue response in radiotherapy for head and neck cancers. Maciejewski B; Skladowski K; Zajusz A Neoplasma; 1991; 38(5):513-22. PubMed ID: 1956467 [TBL] [Abstract][Full Text] [Related]
22. Estimation of the dividing fraction and potential doubling time of tumors using cytochalasin B. Shibamoto Y; Streffer C Cancer Res; 1991 Oct; 51(19):5134-8. PubMed ID: 1913638 [TBL] [Abstract][Full Text] [Related]
23. Tamoxifen-induced increase in the potential doubling time of MCF-7 xenografts as determined by bromodeoxyuridine labeling and flow cytometry. Sarkaria JN; Gibson DF; Jordan VC; Fowler JF; Lindstrom MJ; Mulcahy RT Cancer Res; 1993 Sep; 53(18):4413-7. PubMed ID: 8364937 [TBL] [Abstract][Full Text] [Related]
24. Cell loss and the concept of potential doubling time. Bertuzzi A; Gandolfi A; Sinisgalli C; Starace G; Ubezio P Cytometry; 1997 Sep; 29(1):34-40. PubMed ID: 9298809 [TBL] [Abstract][Full Text] [Related]
25. Proliferative activity and micronucleus frequency after radiation of lung cancer cells as assessed by the cytokinesis-block method and their relationship to clinical outcome. Shibamoto Y; Ike O; Mizuno H; Fukuse T; Hitomi S; Takahashi M Clin Cancer Res; 1998 Mar; 4(3):677-82. PubMed ID: 9533537 [TBL] [Abstract][Full Text] [Related]
26. Influence of sampling time on assessment of potential doubling time. Høyer M; Bentzen SM; Salling LN; Overgaard J Cytometry; 1994 Jun; 16(2):144-51. PubMed ID: 7924683 [TBL] [Abstract][Full Text] [Related]
27. The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer: a multicenter analysis. Begg AC; Haustermans K; Hart AA; Dische S; Saunders M; Zackrisson B; Gustaffson H; Coucke P; Paschoud N; Hoyer M; Overgaard J; Antognoni P; Richetti A; Bourhis J; Bartelink H; Horiot JC; Corvo R; Giaretti W; Awwad H; Shouman T; Jouffroy T; Maciorowski Z; Dobrowsky W; Struikmans H; Wilson GD Radiother Oncol; 1999 Jan; 50(1):13-23. PubMed ID: 10225552 [TBL] [Abstract][Full Text] [Related]
28. Repopulation of FaDu human squamous cell carcinoma during fractionated radiotherapy correlates with reoxygenation. Petersen C; Zips D; Krause M; Schöne K; Eicheler W; Hoinkis C; Thames HD; Baumann M Int J Radiat Oncol Biol Phys; 2001 Oct; 51(2):483-93. PubMed ID: 11567825 [TBL] [Abstract][Full Text] [Related]
29. Changes in cell proliferative parameters of SCCVII and EMT6 murine tumors after single-dose irradiation. Murata R; Nishimura Y; Shibamoto Y; Hiraoka M; Abe M Jpn J Cancer Res; 1996 Jun; 87(6):662-8. PubMed ID: 8766532 [TBL] [Abstract][Full Text] [Related]
30. Tumor repopulation during radiotheraphy: quantitation in two xenografted human tumors. Durand RE Int J Radiat Oncol Biol Phys; 1997 Nov; 39(4):803-8. PubMed ID: 9369126 [TBL] [Abstract][Full Text] [Related]
31. Repopulation of moderately well-differentiated and keratinizing GL human squamous cell carcinomas growing in nude mice. Hessel F; Krause M; Petersen C; Hörcsöki M; Klinger T; Zips D; Thames HD; Baumann M Int J Radiat Oncol Biol Phys; 2004 Feb; 58(2):510-8. PubMed ID: 14751522 [TBL] [Abstract][Full Text] [Related]
32. [Effect of growth rate of monolayer cells on survival after fractionated irradiation]. Takemasa K Nihon Igaku Hoshasen Gakkai Zasshi; 1992 Jul; 52(7):1007-15. PubMed ID: 1508644 [TBL] [Abstract][Full Text] [Related]
33. Influence of overall treatment time and radiobiological parameters on biologically effective doses in cervical cancer patients treated with radiation therapy alone. Gasinska A; Fowler JF; Lind BK; Urbanski K Acta Oncol; 2004; 43(7):657-66. PubMed ID: 15545186 [TBL] [Abstract][Full Text] [Related]
35. In vivo cell kinetics in head and neck squamous cell carcinomas predicts local control and helps guide radiotherapy regimen. Corvò R; Giaretti W; Sanguineti G; Geido E; Orecchia R; Guenzi M; Margarino G; Bacigalupo A; Garaventa G; Barbieri M J Clin Oncol; 1995 Aug; 13(8):1843-50. PubMed ID: 7636527 [TBL] [Abstract][Full Text] [Related]
36. Repopulation in murine skin after X-ray treatments with multiple fractions per day. Tsang RW; Joiner MC; Rojas A; Johns H Radiat Res; 1991 Feb; 125(2):163-72. PubMed ID: 1996374 [TBL] [Abstract][Full Text] [Related]
37. Potentiation of radiation-induced regrowth delay in murine tumors by fludarabine. Grégoire V; Hunter N; Milas L; Brock WA; Plunkett W; Hittelman WN Cancer Res; 1994 Jan; 54(2):468-74. PubMed ID: 8275483 [TBL] [Abstract][Full Text] [Related]
38. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1. Lunsford LD; Flickinger JC; Larson D Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030 [TBL] [Abstract][Full Text] [Related]
39. [Cell kinetics of human solid tumors and biological basis for fractionated radiotherapy]. Sasaki T; Mashiyama S Gan No Rinsho; 1985 Sep; 31(12):1502-11. PubMed ID: 4079038 [TBL] [Abstract][Full Text] [Related]
40. Heterogeneity in the fractionation sensitivities of human tumor cell lines: studies in a three-dimensional model system. Stuschke M; Budach V; Stüben G; Streffer C; Sack H Int J Radiat Oncol Biol Phys; 1995 May; 32(2):395-408. PubMed ID: 7751182 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]